American Portfolios Advisors’s Mustang Bio MBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-5
Closed -$12.5K 3516
2021
Q2
$12.5K Hold
5
﹤0.01% 2405
2021
Q1
$12.5K Hold
5
﹤0.01% 2279
2020
Q4
$14.3K Hold
5
﹤0.01% 1967
2020
Q3
$11.9K Hold
5
﹤0.01% 1913
2020
Q2
$12K Hold
5
﹤0.01% 1852
2020
Q1
$10.1K Buy
+5
New +$12.8K ﹤0.01% 1808

Other funds holding MBIO

American Portfolios Advisors's MBIO Position: Q3 2021 in Review

American Portfolios Advisors sold out of Mustang Bio (MBIO) in Q3 2021, closing a stake of 5 shares — an estimated $12.5K sold.

American Portfolios Advisors first reported a position in MBIO in Q1 2020 and held it in 6 quarters. The position peaked at $14.3K in Q4 2020. 79 funds tracked by Wall St. Rank hold MBIO as of Q3 2021.

  • American Portfolios Advisors reported no remaining Mustang Bio position as of Q3 2021 after selling out during the quarter.
  • American Portfolios Advisors sold 5 Mustang Bio shares in Q3 2021, an estimated $12.5K.
  • American Portfolios Advisors first reported a position in Mustang Bio in Q1 2020 and held it in 6 quarters.
  • American Portfolios Advisors's Mustang Bio position peaked at $14.3K in Q4 2020.
  • 79 funds tracked by Wall St. Rank held Mustang Bio as of Q3 2021.

Based on American Portfolios Advisors's 13F filing for Q3 2021, filed 22 Mar 2023.